Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Austria Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20083
20092
20102
20111
20131
20151
20162
20172
20181
20201
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Eli Lilly and Company4
Novo Nordisk A/S4
Medical University of Vienna3
Amgen1
Bayer1
Corcept Therapeutics1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 221
Diabetes Mellitus6
Obesity3
Renal Insufficiency, Chronic3
Hypertension2
Renal Insufficiency2
ACTH Syndrome, Ectopic1
Adrenal Cortex Neoplasms1
Adrenocortical Carcinoma1
Cushing Syndrome1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.